公开(公告)号：EP2580225A1

公开(公告)日：2013-04-17

申请号：EP11791943.1

申请日：2011-06-10

申请人： Theracos, Inc.

发明人： CAI, Mengzhuang ,  LIU, Qian ,  XU, Ge ,  LV, Binhua ,  SEED, Brian ,  ROBERGE, Jacques Y.

IPC分类号： C07H7/04 ,  A61K31/70 ,  A61P3/00

CPC分类号： C07H1/06 ,  C07D309/10 ,  C07H7/04

摘要： Provided are crystalline forms of a compound having an inhibitory effect on sodium-dependent glucose cotransporter SGLT2. The invention also provides pharmaceutical compositions, methods of preparing the crystalline compound, and methods of using the crystalline compound, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT or SGLT2 inhibition.